Karin Hellsvik brings 15 years of passion for improving patient care to her current position as Sr Director, Head of Patient Advocacy and External Communications Alzheimer's at Biogen. She sets the patient advocacy and external communications strategy for Biogen's Alzheimer's disease program and is responsible for engaging with patient organizations, campaigning health groups and policy makers around projects that improve health outcomes in the US and internationally. Prior to assuming this role, she spent 4 years at Biogen's international headquarters in Switzerland defining and establishing the Patient Advocacy function and strategy in Europe for the company's disease areas. Before taking on the European role, she served as Biogen's Head of Patient Communications in the Nordic region, based in Copenhagen. Prior to joining Biogen in 2010, Karin employed her educational background in communications at a leading Nordic healthcare communications agency, where she gained many years of experience consulting with a broad range of clients focusing on pharma communications and advocacy.